Lancet:中国慢性肾脏病流行病学调查数据公布,中国高达1.2亿人

2012-03-09 MedSci MedSci原创

国际著名杂志《柳叶刀》The Lancet在线刊登了北大医院肾脏内科王海燕教授的最新研究成果“中国慢性肾脏病流行病学调查”(Prevalence of chronic kidney disease in China: a cross-sectional survey),文章中,研究者对中国慢性肾脏病流行病进行了统计以及调查研究。 “中国慢性肾脏病流行病学调查”是由科技部“十一五”科技支撑计

国际著名杂志《柳叶刀》The Lancet在线刊登了北大医院肾脏内科王海燕教授的最新研究成果“中国慢性肾脏病流行病学调查”(Prevalence of chronic kidney disease in China: a cross-sectional survey),文章中,研究者对中国慢性肾脏病流行病进行了统计以及调查研究。

“中国慢性肾脏病流行病学调查”是由科技部“十一五”科技支撑计划资助、涉及全国13个省市、自治区的全国性横断面研究。该研究历时4年,对于全国近5万名18岁以上成年居民进行了慢性肾脏病的调查。研究采用多阶段分层抽样的设计方法获取能够代表中国成年人群的调查对象,应用基于肌酐的估计肾小球滤过率和尿白蛋白/肌酐比值评价有无肾脏病,并应用复合权重的统计学方法对于患病率进行校正、使之能够反映中国成年人群的情况。调查结果显示,我国成年人群中慢性肾脏病的患病率为10.8%,据此估计我国现有成年慢性肾脏病患者1.2亿;而慢性肾脏病的知晓率仅为12.5%。该调查还发现经济快速发展的农村地区居民成为慢性肾脏病的高发人群,推测与高血压糖尿病等代谢性疾病的激增及医疗保健欠完善有关。

《柳叶刀》杂志为该研究论文配发题为《龙年伊始:中国是否将迎来慢性肾脏病的流行》的述评,对于研究的重要性给予高度评价。

doi:10.1016/S0140-6736(12)60033-6
Prevalence of chronic kidney disease in China: a cross-sectional survey

Luxia Zhang MD a *, Fang Wang MD a *, Prof Li Wang MD b †, Prof Wenke Wang MD c †, Prof Bicheng Liu MD d †, Prof Jian Liu MD e †, Prof Menghua Chen MD f †, Prof Qiang He MD g †, Prof Yunhua Liao MD h †, Prof Xueqing Yu MD i †, Prof Nan Chen MD j †, Prof Jian-e Zhang MD k, Prof Zhao Hu MD l, Prof Fuyou Liu MD m, Daqing Hong MD b, Lijie Ma MD c, Hong Liu MD d, Xiaoling Zhou MD f, Jianghua Chen MD g, Ling Pan MD h, Wei Chen MD i, Weiming Wang MD j, Prof Xiaomei Li MD a, Prof Haiyan Wang MD a

Background The prevalence of chronic kidney disease is high in developing countries. However, no national survey of chronic kidney disease has been done incorporating both estimated glomerular filtration rate (eGFR) and albuminuria in a developing country with the economic diversity of China. We aimed to measure the prevalence of chronic kidney disease in China with such a survey.

Methods We did a cross-sectional survey of a nationally representative sample of Chinese adults. Chronic kidney disease was defined as eGFR less than 60 mL/min per 1·73 m2 or the presence of albuminuria. Participants completed a lifestyle and medical history questionnaire and had their blood pressure measured, and blood and urine samples taken. Serum creatinine was measured and used to estimate glomerular filtration rate. Urinary albumin and creatinine were tested to assess albuminuria. The crude and adjusted prevalence of indicators of kidney damage were calculated and factors associated with the presence of chronic kidney disease analysed by logistic regression.

Findings 50 550 people were invited to participate, of whom 47 204 agreed. The adjusted prevalence of eGFR less than 60 mL/min per 1·73 m2 was 1·7% (95% CI 1·5—1·9) and of albuminuria was 9·4% (8·9—10·0). The overall prevalence of chronic kidney disease was 10·8% (10·2—11·3); therefore the number of patients with chronic kidney disease in China is estimated to be about 119·5 million (112·9—125·0 million). In rural areas, economic development was independently associated with the presence of albuminuria. The prevalence of chronic kidney disease was high in north (16·9% [15·1—18·7]) and southwest (18·3% [16·4—20·4]) regions compared with other regions. Other factors independently associated with kidney damage were age, sex, hypertension, diabetes, history of cardiovascular disease, hyperuricaemia, area of residence, and economic status.

Interpretation Chronic kidney disease has become an important public health problem in China. Special attention should be paid to residents in economically improving rural areas and specific geographical regions in China.

Funding The Ministry of Science and Technology (China); the Science and Technology Commission of Shanghai; the National Natural Science Foundation of China; the Department of Health, Jiangsu Province; the Sichuan Science and Technology Department; the Ministry of Education (China); the International Society of Nephrology Research Committee; and the China Health and Medical Development Foundation.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1827376, encodeId=46c5182e37666, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Fri Jun 22 06:46:00 CST 2012, time=2012-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411187, encodeId=cb40141118e44, content=<a href='/topic/show?id=91e96538eee' target=_blank style='color:#2F92EE;'>#流行病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65387, encryptionId=91e96538eee, topicName=流行病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Sun Mar 11 12:46:00 CST 2012, time=2012-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1423778, encodeId=a21c1423e780a, content=<a href='/topic/show?id=abfd6539566' target=_blank style='color:#2F92EE;'>#流行病学调查#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65395, encryptionId=abfd6539566, topicName=流行病学调查)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bc93846316, createdName=charl1234568, createdTime=Sun Mar 11 12:46:00 CST 2012, time=2012-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616038, encodeId=03f41616038bc, content=<a href='/topic/show?id=9c95536521c' target=_blank style='color:#2F92EE;'>#慢性肾脏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53652, encryptionId=9c95536521c, topicName=慢性肾脏)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=305019728622, createdName=12498b08m96暂无昵称, createdTime=Sun Mar 11 12:46:00 CST 2012, time=2012-03-11, status=1, ipAttribution=)]
    2012-06-22 howi
  2. [GetPortalCommentsPageByObjectIdResponse(id=1827376, encodeId=46c5182e37666, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Fri Jun 22 06:46:00 CST 2012, time=2012-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411187, encodeId=cb40141118e44, content=<a href='/topic/show?id=91e96538eee' target=_blank style='color:#2F92EE;'>#流行病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65387, encryptionId=91e96538eee, topicName=流行病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Sun Mar 11 12:46:00 CST 2012, time=2012-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1423778, encodeId=a21c1423e780a, content=<a href='/topic/show?id=abfd6539566' target=_blank style='color:#2F92EE;'>#流行病学调查#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65395, encryptionId=abfd6539566, topicName=流行病学调查)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bc93846316, createdName=charl1234568, createdTime=Sun Mar 11 12:46:00 CST 2012, time=2012-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616038, encodeId=03f41616038bc, content=<a href='/topic/show?id=9c95536521c' target=_blank style='color:#2F92EE;'>#慢性肾脏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53652, encryptionId=9c95536521c, topicName=慢性肾脏)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=305019728622, createdName=12498b08m96暂无昵称, createdTime=Sun Mar 11 12:46:00 CST 2012, time=2012-03-11, status=1, ipAttribution=)]
    2012-03-11 xugumin
  3. [GetPortalCommentsPageByObjectIdResponse(id=1827376, encodeId=46c5182e37666, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Fri Jun 22 06:46:00 CST 2012, time=2012-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411187, encodeId=cb40141118e44, content=<a href='/topic/show?id=91e96538eee' target=_blank style='color:#2F92EE;'>#流行病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65387, encryptionId=91e96538eee, topicName=流行病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Sun Mar 11 12:46:00 CST 2012, time=2012-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1423778, encodeId=a21c1423e780a, content=<a href='/topic/show?id=abfd6539566' target=_blank style='color:#2F92EE;'>#流行病学调查#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65395, encryptionId=abfd6539566, topicName=流行病学调查)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bc93846316, createdName=charl1234568, createdTime=Sun Mar 11 12:46:00 CST 2012, time=2012-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616038, encodeId=03f41616038bc, content=<a href='/topic/show?id=9c95536521c' target=_blank style='color:#2F92EE;'>#慢性肾脏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53652, encryptionId=9c95536521c, topicName=慢性肾脏)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=305019728622, createdName=12498b08m96暂无昵称, createdTime=Sun Mar 11 12:46:00 CST 2012, time=2012-03-11, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1827376, encodeId=46c5182e37666, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Fri Jun 22 06:46:00 CST 2012, time=2012-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411187, encodeId=cb40141118e44, content=<a href='/topic/show?id=91e96538eee' target=_blank style='color:#2F92EE;'>#流行病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65387, encryptionId=91e96538eee, topicName=流行病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Sun Mar 11 12:46:00 CST 2012, time=2012-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1423778, encodeId=a21c1423e780a, content=<a href='/topic/show?id=abfd6539566' target=_blank style='color:#2F92EE;'>#流行病学调查#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65395, encryptionId=abfd6539566, topicName=流行病学调查)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bc93846316, createdName=charl1234568, createdTime=Sun Mar 11 12:46:00 CST 2012, time=2012-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616038, encodeId=03f41616038bc, content=<a href='/topic/show?id=9c95536521c' target=_blank style='color:#2F92EE;'>#慢性肾脏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53652, encryptionId=9c95536521c, topicName=慢性肾脏)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=305019728622, createdName=12498b08m96暂无昵称, createdTime=Sun Mar 11 12:46:00 CST 2012, time=2012-03-11, status=1, ipAttribution=)]

相关资讯

Nat Med:首次发现人肾脏足状突细胞可以再生

足状突细胞(podocyte)是肾脏中一种特殊类型的上皮细胞。在90%以上的所有慢性肾脏疾病当中,足状突细胞受损。如今,美国斯坦福大学医学院发现一种意想不到但又常见的Wnt信号传导途径调控足状突细胞再生,这也是第一次揭示这些细胞在肾脏发挥正常功能期间如何可以再生和自我更新。这一发现是一次重大的进步以便人们有朝一日治疗性地诱导这些细胞发生分裂,从而能够用来治疗慢性肾脏疾病。2011年12月4日,这些

糖皮质激素治疗肾脏疾病的专家共识

糖皮质激素治疗肾脏疾病的专家共识.pdf

肾脏同种异体移植物的排斥反应

 在过去的半个世纪里,肾移植科学已取得了相当大的进展,主要有以下原因:对免疫系统在同种异体移植物排斥反应中的作用有了进一步了解,解开了移植物失功背后分子机制的谜团,以及免疫抑制得到了更好的管理1,2。排斥反应一直是(肾移植)的主要障碍。来自供者(在遗传学上不同于移植物受者)的组织或细胞移植,在受者中可引起一种抗供者移植物异型抗原的免疫应答,如果得不到控制,这种应答会破坏移植物。   最近已有发

2011年中国肾病领域关键进展汇总

    在临床学科中,肾脏病学科一直是开展临床研究十分活跃的学科之一,也是临床极具有挑战性学科。这里回顾2011年中国科研工作者在肾病领域的主要贡献。   我国慢性肾病“沾亲带故” 近三成一级亲属患慢性肾病   中山大学附属第一医院 余学清   中山大学附属第一医院肾内科余学清教授等开展的一项横断面研究提示,慢性肾脏病(CKD)患者的一级亲属罹患CKD 的